查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1522235

2024年體外肺部模型全球市場報告

In-Vitro Lung Model Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

體外肺模型市場規模預計在未來幾年將呈指數級成長，預計到2028年將成長至9.6億美元，複合年成長率為21.1%。預測期內的預期成長受到多種因素的推動，特別是藥物開發的需求、臨床前測試的升級、對呼吸毒理學認知的提高、再生醫學的大力投入、日益成長的環境問題，這與以下因素有關老年人口的增加。預測期內的主要特異性包括藥物測試需求的增加、3D列印和器官晶片技術的進步、人工智慧和機器學習的整合、感測器和監測設備的引入以及各種非藥物應用的開發。

臨床試驗的激增預計將在未來幾年推動體外肺模型市場的成長。臨床試驗是一項評估新醫學方法對人類有效性的研究。臨床研究的成長是由對先進醫學不斷成長的需求、不斷成長的醫療保健需求以及對複雜健康挑戰的創新解決方案的探索所推動的。體外肺模型提供了一個受控環境來檢查物質如何影響肺組織，可用於測試藥物、評估毒性、建模疾病和了解疾病機制，並在臨床試驗中發揮重要作用。例如，根據美國臨床試驗註冊中心 ClinicalTrials.gov 的數據，截至 2024 年 1 月，全球整體註冊的臨床試驗數量為 477,230 項，高於 2022 年的 437,508 項。因此，越來越多的臨床試驗正在刺激體外肺部模型市場。

體外肺模型市場的主要參與者正在開發 3D 呼吸組織模型，以提高生理相關性和模型複雜性。這些模型是透過在專門的環境中培養選定的呼吸細胞而創建的，使它們能夠形成模仿呼吸系統功能和形態的3D結構。這為研究和藥物測試提供了一個更生理相關的平台。例如，2023年4月，美國生物技術公司MatTek公司推出了EpiNasal，這是一種由原代人類鼻上皮細胞製成的創新3D呼吸組織模型。 EpiNasal 再現鼻上皮的3D結構和功能，包括產生黏液的杯狀細胞、功能性緊密連接和跳動的纖毛。 EpiNasal 簡介擴展了 MatTek 的 3D 呼吸組織模型範圍，並提供了一個用於研究藥物、化學物質、病原體和消費品對人體呼吸系統影響的綜合系統。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 市場促進和限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年市場規模表現與成長
  • 市場規模預測與成長，2023-2028，2033F

第6章 市場細分

  • 全球體外肺模型市場：按類型分類的表現和預測，2018-2023、2023-2028F、2033F
  • 2D (2D) 模型
  • 3D(3D) 模型
  • 全球體外肺模型市場：按應用分類的表現和預測，2018-2023、2023-2028F、2033F
  • 藥物發現和毒理學研究
  • 生理學調查
  • 3D(3D) 模型開發
  • 其他
  • 全球體外肺模型市場：最終用戶的表現和預測，2018-2023、2023-2028F、2033F
  • 學術研究所
  • 製藥和生物技術公司
  • 其他

第 7 章 區域/國家分析

  • 全球體外肺模型市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球體外肺模型市場：按國家分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 體外肺部模型市場：競爭格局
  • 體外肺模型市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • PerkinElmer Inc.
    • Charles River Laboratories International Inc.
    • Varian Medical Systems Inc.

第31章 其他大型創新企業

  • Epithelix
  • The Charles Stark Draper Laboratory Inc.
  • STEMCELL Technologies
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero
  • Emulate Inc.
  • PhoenixBio Co. Ltd.
  • Newcells Biotech
  • CN Bio Innovations Ltd.
  • Mimetas
  • Cyfuse Biomedical KK
  • 3D Biotek LLC
  • AlveoliX AG
  • AxoSim Technologies LLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18388

An in vitro lung model is a scientific construct devised to replicate the cellular, structural, and functional characteristics of the human lung within a controlled laboratory setting. These models empower researchers to explore disease progression, identify biomarkers, and evaluate treatment effectiveness. They serve as invaluable instruments for advancing our comprehension of lung biology, refining therapeutic approaches, and enhancing health outcomes.

The primary classifications of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model presents a simplified depiction of lung cells and tissue on a flat surface, employed in fundamental research and preliminary substance testing. They find utility across various domains such as drug discovery, toxicology assessments, physiological investigations, as well as the advancement of three-dimensional (3D) model methodologies. These models are utilized by academic research institutions, pharmaceutical and biotechnology firms, among others.

The in vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in vitro lung model market statistics, including the in vitro lung model industry global market size, regional shares, competitors with in vitro lung model market share, detailed in vitro lung model market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro lung model industry. These in vitro lung model market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro lung model market size has grown exponentially in recent years. It will grow from $0.37 billion in 2023 to $0.44 billion in 2024 at a compound annual growth rate (CAGR) of 21%. The expansion observed during the historical period can be credited to several factors, including the rising incidence of respiratory ailments, heightened attention to personalized medicine, increased exploration of drug repurposing, a focus on precision medicine methodologies, and heightened recognition of environmental health hazards.

The vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $0.96 billion in 2028 at a compound annual growth rate (CAGR) of 21.1%. The anticipated growth in the forecast period can be linked to various factors, notably the demand for drug development, the escalation in preclinical testing, heightened awareness regarding respiratory toxicology, a concentrated effort on regenerative medicine, escalating environmental apprehensions, and the rising population of older adults. Key trends expected in the forecast period encompass heightened demand for drug testing, advancements in 3D printing and organ-on-chip technologies, the integration of AI and machine learning, incorporation of sensors and monitoring apparatuses, diversification of applications beyond pharmaceuticals, and the formulation of disease-specific models.

The surge in clinical studies is anticipated to drive growth in the in vitro lung model market in the future. Clinical trials are investigations that evaluate the effectiveness of new medical approaches in human subjects. This increase in clinical studies is propelled by the growing demand for advanced medical treatments, rising healthcare needs, and the search for innovative solutions to complex health challenges. In vitro lung models play a crucial role in clinical trials by providing a controlled setting to examine how substances affect lung tissue, aiding in drug testing, assessing toxicity, modeling diseases, and understanding disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, as of January 2024, there were 477,230 registered clinical trials globally, up from 437,508 in 2022. Consequently, the rise in clinical studies stimulates the in vitro lung model market.

Key players in the in vitro lung model market are developing 3D respiratory tissue models to enhance the physiological relevance and complexity of their models. These models are created by culturing selected respiratory cells in a specialized environment, allowing them to form a three-dimensional structure that mimics the function and morphology of the respiratory system. This provides a more physiologically relevant platform for research and drug testing. For example, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. EpiNasal replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and beating cilia. The introduction of EpiNasal expands MatTek's range of 3D respiratory tissue models, offering a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

In March 2021, CELLINK, a US-based bioconvergence company, acquired MatTek Corporation for an undisclosed sum. Through this acquisition, CELLINK aims to merge its expertise in lab-engineered human tissue with bioprinting technology to pioneer alternative test models, thereby reducing reliance on animal testing. This aligns with their vision of revolutionizing medicine through accurate, ethical testing and expanding scientific impact. MatTek Corporation is a US-based biotechnology company specializing in in vitro human tissue model innovation as a reliable alternative to animal testing.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc. , STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Lung Model Market Characteristics

3. In-Vitro Lung Model Market Trends And Strategies

4. In-Vitro Lung Model Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global In-Vitro Lung Model Market Size and Growth

  • 5.1. Global In-Vitro Lung Model Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global In-Vitro Lung Model Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global In-Vitro Lung Model Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. In-Vitro Lung Model Market Segmentation

  • 6.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Two-Dimensional (2D) Model
  • Three-Dimensional (3D) Model
  • 6.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery And Toxicology Studies
  • Physiological Research
  • Three-Dimensional (3D) Model Development
  • Other Applications
  • 6.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users

7. In-Vitro Lung Model Market Regional And Country Analysis

  • 7.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific In-Vitro Lung Model Market

  • 8.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China In-Vitro Lung Model Market

  • 9.1. China In-Vitro Lung Model Market Overview
  • 9.2. China In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India In-Vitro Lung Model Market

  • 10.1. India In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan In-Vitro Lung Model Market

  • 11.1. Japan In-Vitro Lung Model Market Overview
  • 11.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia In-Vitro Lung Model Market

  • 12.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia In-Vitro Lung Model Market

  • 13.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea In-Vitro Lung Model Market

  • 14.1. South Korea In-Vitro Lung Model Market Overview
  • 14.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe In-Vitro Lung Model Market

  • 15.1. Western Europe In-Vitro Lung Model Market Overview
  • 15.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK In-Vitro Lung Model Market

  • 16.1. UK In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany In-Vitro Lung Model Market

  • 17.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France In-Vitro Lung Model Market

  • 18.1. France In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy In-Vitro Lung Model Market

  • 19.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain In-Vitro Lung Model Market

  • 20.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe In-Vitro Lung Model Market

  • 21.1. Eastern Europe In-Vitro Lung Model Market Overview
  • 21.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia In-Vitro Lung Model Market

  • 22.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America In-Vitro Lung Model Market

  • 23.1. North America In-Vitro Lung Model Market Overview
  • 23.2. North America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA In-Vitro Lung Model Market

  • 24.1. USA In-Vitro Lung Model Market Overview
  • 24.2. USA In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada In-Vitro Lung Model Market

  • 25.1. Canada In-Vitro Lung Model Market Overview
  • 25.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America In-Vitro Lung Model Market

  • 26.1. South America In-Vitro Lung Model Market Overview
  • 26.2. South America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil In-Vitro Lung Model Market

  • 27.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East In-Vitro Lung Model Market

  • 28.1. Middle East In-Vitro Lung Model Market Overview
  • 28.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa In-Vitro Lung Model Market

  • 29.1. Africa In-Vitro Lung Model Market Overview
  • 29.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Lung Model Market Competitive Landscape
  • 30.2. In-Vitro Lung Model Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Lonza Group AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. PerkinElmer Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Charles River Laboratories International Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Varian Medical Systems Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. In-Vitro Lung Model Market Other Major And Innovative Companies

  • 31.1. Epithelix
  • 31.2. The Charles Stark Draper Laboratory Inc.
  • 31.3. STEMCELL Technologies
  • 31.4. American Type Culture Collection (ATCC)
  • 31.5. BioIVT
  • 31.6. InSphero
  • 31.7. Emulate Inc.
  • 31.8. PhoenixBio Co. Ltd.
  • 31.9. Newcells Biotech
  • 31.10. CN Bio Innovations Ltd.
  • 31.11. Mimetas
  • 31.12. Cyfuse Biomedical K.K.
  • 31.13. 3D Biotek LLC
  • 31.14. AlveoliX AG
  • 31.15. AxoSim Technologies LLC

32. Global In-Vitro Lung Model Market Competitive Benchmarking

33. Global In-Vitro Lung Model Market Competitive Dashboard

34. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

35. In-Vitro Lung Model Market Future Outlook and Potential Analysis

  • 35.1 In-Vitro Lung Model Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Lung Model Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Lung Model Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer